Lear
LEA
119.63
-2.37
-1.94%
Lear
US · LEA
#1930 by market cap
Listed 1970
119.63
-2.37
-1.94%
Live - 5344 symbols - heartbeat 479s ago
· 2026-10-08 05:24
Pre-market
120.49
+0.72%
After-hours
119.63
0.00%
Overnight
119.63
0.00%
- Market cap
- 5.90B
- P/E (TTM)i
- 11.14
- P/Bi
- 1.14
- EPSi
- 8.15
- Div yieldi
- 2.57%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on LEA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.85, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.20% YoY
Margins
- Gross margin
- 6.47%
- Operating margin
- 3.34%
- Net margin
- 1.88%
Key ratios & quality
- Enterprise valuei
- 7.78B
- PEG ratioi
- 1.11
- Altman Z-Scorei
- 2.85
PEG uses trailing P/E against the 3-year net income growth rate (10.05%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.15B | 19.81B | 17.05B | 19.26B | 20.89B | 23.47B | 23.31B | 23.26B |
| Gross profit | 2.32B | 1.74B | 1.11B | 1.39B | 1.41B | 1.71B | 1.64B | 1.50B |
| Selling & admin expenses | 612.80M | 605.00M | 588.90M | 643.20M | 684.80M | 714.70M | 702.50M | 707.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.65B | 1.07B | 454.10M | 675.40M | 654.30M | 933.20M | 887.70M | 777.30M |
| Pretax profit | 1.54B | 953.60M | 299.30M | 583.50M | 509.30M | 777.20M | 732.90M | 625.10M |
| Tax | 311.90M | 146.10M | 93.90M | 137.70M | 133.70M | 180.80M | 191.10M | 150.00M |
| Net profit | 1.25B | 830.70M | 233.90M | 461.60M | 408.70M | 645.70M | 591.80M | 527.10M |
| Basic EPS | 17 | 13 | 3 | 6 | 5 | 10 | 9 | 8 |
| Diluted EPS | 17.22 | 12.75 | 2.62 | 6.19 | 5.47 | 9.68 | 8.97 | 8.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 5.56B | 6.03B | 5.68B | 5.99B | 5.82B | 6.21B |
| Gross profit | 359.20M | 439.10M | 363.70M | 342.40M | 450.30M | 470.30M |
| Selling & admin expenses | 172.40M | 186.30M | 166.40M | 182.50M | 190.30M | 197.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 181.60M | 248.10M | 192.50M | 155.10M | 255.00M | 267.90M |
| Pretax profit | 135.40M | 217.50M | 159.40M | 112.80M | 216.70M | 240.90M |
| Tax | 45.20M | 41.60M | 45.10M | 18.10M | 38.40M | 48.50M |
| Net profit | 102.50M | 191.90M | 126.40M | 106.30M | 192.70M | 211.70M |
| Basic EPS | 2 | 3 | 2 | 2 | 3 | 4 |
| Diluted EPS | 1.49 | 3.06 | 2.02 | 1.58 | 3.34 | 3.79 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.28B | 6.41B | 6.78B | 6.77B | 6.99B | 7.64B | 7.18B | 7.66B |
| Cash & ST investments | 1.49B | 1.49B | 1.31B | 1.32B | 1.11B | 1.20B | 1.05B | 1.03B |
| Inventory | 1.20B | 1.26B | 1.40B | 1.57B | 1.57B | 1.76B | 1.60B | 1.69B |
| Total assets | 11.60B | 12.68B | 13.20B | 13.35B | 13.76B | 14.70B | 14.03B | 14.84B |
| Total current liabilities | 4.50B | 4.67B | 5.08B | 4.76B | 5.19B | 5.67B | 5.45B | 5.67B |
| Short-term debt | 22.80M | 147.20M | 130.50M | 126.40M | 157.50M | 179.70M | 181.50M | 201.00M |
| Long-term debt | 1.94B | 2.29B | 2.30B | 2.60B | 2.59B | 2.74B | 2.73B | 2.71B |
| Total liabilities | 7,240,100,000.00 | 8,179,600,000.00 | 8,583,700,000.00 | 8,544,000,000.00 | 8,932,700,000.00 | 9,634,900,000.00 | 9,426,500,000.00 | 9,642,100,000.00 |
| Total equity | 4.36B | 4.50B | 4.61B | 4.81B | 4.83B | 5.06B | 4.60B | 5.20B |
| Retained earnings | 4.11B | 4.72B | 4.81B | 5.07B | 5.21B | 5.60B | 5.93B | 6.19B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 7.72B | 8.22B | 8.03B | 7.66B | 8.25B | 8.39B |
| Cash & ST investments | 779.90M | 887.90M | 1.01B | 1.03B | 881.90M | 1.00B |
| Inventory | 1.68B | 1.68B | 1.76B | 1.69B | 1.75B | 1.72B |
| Total assets | 14.62B | 15.32B | 15.16B | 14.84B | 15.45B | 15.65B |
| Total current liabilities | 5.85B | 6.12B | 5.95B | 5.67B | 6.22B | 6.38B |
| Short-term debt | 29.00M | 30.80M | 31.00M | 201.00M | 32.10M | 32.80M |
| Long-term debt | 2.73B | 2.76B | 2.76B | 2.71B | 2.71B | 2.71B |
| Total liabilities | 9,798,700,000.00 | 10,111,400,000.00 | 9,915,200,000.00 | 9,642,100,000.00 | 10,178,300,000.00 | 10,325,800,000.00 |
| Total equity | 4.82B | 5.21B | 5.24B | 5.20B | 5.28B | 5.32B |
| Retained earnings | 5.96B | 6.08B | 6.15B | 6.19B | 6.32B | 6.47B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.78B | 1.28B | 663.10M | 670.10M | 1.02B | 1.25B | 1.12B | 1.09B |
| Depreciation & amortization | 484.40M | 509.90M | 539.90M | 573.90M | 576.50M | 604.40M | 620.70M | 604.10M |
| Free cash flow | 1.10B | 680.40M | 210.80M | 85.00M | 383.20M | 622.80M | 561.40M | 527.20M |
| Dividends paid | -186.30M | -186.30M | -67.30M | -106.70M | -185.50M | -181.90M | -173.70M | -164.80M |
| Stock buybacks / issuance | -704.90M | -384.70M | -70.00M | -100.30M | -100.30M | -296.50M | -416.70M | -325.20M |
| Ending cash balance | 1.52B | 1.51B | 1.31B | 1.32B | 1.12B | 1.20B | 1.06B | 1.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -127.70M | 296.20M | 444.40M | 475.90M | 98.10M | 460.50M |
| Depreciation & amortization | 147.70M | 148.20M | 152.30M | 155.90M | 149.90M | 150.60M |
| Free cash flow | -231.70M | 170.80M | 307.00M | 281.10M | -26.50M | 287.80M |
| Dividends paid | -43.30M | -41.20M | -40.90M | -39.40M | -42.50M | -38.70M |
| Stock buybacks / issuance | -25.00M | -22.50M | -102.60M | -175.10M | -75.00M | -100.00M |
| Ending cash balance | 782.70M | 893.30M | 1.01B | 1.04B | 884.50M | 1.00B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 27.29 | 18.47 | 3.60 | 8.21 | 7.03 | 11.93 | 10.81 | 9.21 |
| ROA %i | 9.68 | 6.50 | 1.22 | 2.82 | 2.42 | 4.02 | 3.53 | 3.03 |
| ROIC %i | 19.66 | 13.39 | 3.31 | 6.23 | 5.41 | 8.51 | 7.69 | 6.71 |
| 5-year avg ROE %i | 28.67 | 27.88 | 23.53 | 18.66 | 12.92 | 9.85 | 8.32 | 9.44 |
| EBIT margin %i | 7.67 | 5.28 | 2.34 | 3.51 | 2.91 | 3.74 | 3.60 | 3.12 |
| FCF / sales %i | 5.21 | 3.43 | 1.24 | 0.44 | 1.83 | 2.65 | 2.41 | 2.27 |
| Current ratioi | 1.40 | 1.37 | 1.33 | 1.42 | 1.35 | 1.35 | 1.32 | 1.35 |
| Quick ratioi | 0.97 | 0.96 | 0.90 | 0.92 | 0.88 | 0.86 | 0.85 | 0.87 |
| Debt / assetsi | 16.93 | 19.25 | 18.42 | 20.38 | 19.97 | 19.89 | 20.78 | 19.62 |
| LT debt / equityi | 46.21 | 52.73 | 51.49 | 55.89 | 55.38 | 55.76 | 61.40 | 53.85 |
| Interest coveragei | 19.29 | 11.37 | 4.01 | 7.36 | 6.17 | 8.69 | 7.90 | 7.20 |
| Revenue CAGR (3Y) %i | 5.11 | 2.20 | -5.92 | -3.06 | 1.79 | 11.25 | 6.56 | 3.64 |
| Net income CAGR (3Y) %i | 15.54 | -8.23 | -50.58 | -31.23 | -24.24 | 53.43 | 10.65 | 10.05 |
| FCF CAGR (3Y) %i | 11.98 | -14.56 | -43.82 | -57.44 | -17.42 | 43.49 | 87.62 | 11.22 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 10.00 | 8.03 | 8.96 | 9.21 | 10.84 | 10.84 |
| ROA %i | 3.24 | 2.65 | 2.95 | 3.03 | 3.51 | 3.59 |
| ROIC %i | 7.35 | 6.14 | 6.67 | 6.71 | 7.98 | 8.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.57 | 3.93 | 3.37 | 3.12 | 3.43 | 3.50 |
| FCF / sales %i | 2.09 | 2.76 | 3.20 | 2.27 | 3.11 | 3.58 |
| Current ratioi | 1.32 | 1.34 | 1.35 | 1.35 | 1.33 | 1.31 |
| Quick ratioi | 0.86 | 0.89 | 0.88 | 0.87 | 0.81 | 0.82 |
| Debt / assetsi | 18.89 | 18.22 | 18.41 | 19.62 | 17.75 | 17.55 |
| LT debt / equityi | 58.67 | 54.32 | 54.05 | 53.85 | 53.31 | 52.38 |
| Interest coveragei | 7.72 | 6.52 | 7.55 | 7.20 | 8.02 | 8.34 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Seating is the largest reported line at 74.48% of revenue, across 3 reported segments.
- The next-largest line, E-Systems, is a distant second at 26.69% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Seating74.48%
E-Systems26.69%
Quote time 2026-10-08 05:24:01 · For reference only, not investment advice and not tailored to your situation.